Why the North America Pharmacogenetics Testing in...

ha aggiunto una foto Altre informazioni

2025-12-23 08:43:57 -

Why the North America Pharmacogenetics Testing in Psychiatry/Depression Market Is Leading Genetic-Based Mental Health Care

"Executive Summary North America Pharmacogenetics Testing in Psychiatry/Depression Market Size and Share: Global Industry Snapshot CAGR Value Data Bridge Market Research analyzes that the North America pharmacogenetics testing in psychiatry/depression market is expected to reach the value of USD 981.28 million by 2029, at a CAGR of 9.7% during the forecast period. For the growth of...

0 Commenti 0 condivisioni 13 Views